JNJ-43260295
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JNJ-43260295, covering 2016-03-23 to 2016-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma [Phase 1]